£75.60

Springer Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Price data last checked 97 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£76 today · usual range £0–£0 · best ever £69

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 634 days • 634 data points (No recent data available)

Historical
Generating forecast...
£75.73 £68.74 £70.27 £71.79 £73.32 £74.84 £76.37 10 June 2024 15 November 2024 22 April 2025 27 September 2025 05 March 2026

Price Distribution

Price distribution over 634 days • 6 price levels

Days at Price
Current Price
39 days 196 days 199 days 90 days 36 days 74 days · current 0 50 100 149 199 £69 £71 £72 £73 £75 £76 Days at Price

Price Analysis

Most common price: £72 (199 days, 31.4%)

Price range: £69 - £76

Price levels: 6 different prices over 634 days

Description

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
07 May 2018
Listed Since
20 February 2018

Barcode

No barcode data available

Similar Products You Might Like

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
97% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£78.10 01 Mar 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
96% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£152.38 19 Dec 2025
Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)
96% match

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Springer

£75.01 10 Mar 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
96% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Image-Guided Radiation Therapy in Lymphoma Management: The Increasing Role of Functional Imaging
96% match

Image-Guided Radiation Therapy in Lymphoma Management: The Increasing Role of Functional Imaging

CRC Press

£193.52 26 Jan 2026
Aggressive Lymphomas (Hematologic Malignancies)
96% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£88.97 08 Mar 2026
Rare Lymphomas (Hematologic Malignancies)
96% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£109.04 19 Dec 2025
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
96% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£69.58 07 Mar 2026
Radiotherapy for Hodgkin Lymphoma
96% match

Radiotherapy for Hodgkin Lymphoma

Springer

£66.19 11 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
96% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 09 Mar 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£179.99 08 Apr 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£291.99 11 Jan 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
96% match

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

CRC Press

£147.25 13 Apr 2026
Lymphoma and Leukemia of the Nervous System
95% match

Lymphoma and Leukemia of the Nervous System

Springer

£107.85 02 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
95% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 09 Mar 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
95% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£117.00 28 Feb 2026
T-Cell Lymphomas (Contemporary Hematology)
95% match

T-Cell Lymphomas (Contemporary Hematology)

Humana

£79.93 23 Feb 2026
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)
95% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)

Springer

£113.11 07 Jan 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
95% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.36 01 Mar 2026
Adult T-cell Leukemia/Lymphoma
95% match

Adult T-cell Leukemia/Lymphoma

Springer

£98.92 09 Jan 2026
PET/CT in Lymphomas: A Case-Based Atlas
95% match

PET/CT in Lymphomas: A Case-Based Atlas

Springer

£85.16 09 Mar 2026
Novel Therapeutics for Rare Lymphomas
95% match

Novel Therapeutics for Rare Lymphomas

Springer

£61.26 28 Feb 2026
Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy
95% match

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Springer

£78.77 26 Feb 2026